Morning Overview on MSN
An mRNA vaccine paired with Keytruda cut melanoma recurrence by nearly 50% over five years in a landmark NYU-led trial
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...
2don MSN
Researchers use AI and genetic data to create new vaccine capable of combating viral mutations
The researchers created a "super-antigen" capable of combating a whole family of viruses, even if they mutate.
New vaccine technology created with the help of artificial intelligence could provide immunity against whole families of ...
A groundbreaking new vaccine technology using artificial intelligence could offer immunity against entire families of viruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results